comparemela.com

Page 7 - Leonard Schleifer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HHS allocates $1 4B to develop new COVID-19 vaccines

Project NextGen will receive a $1.4 billion boost in funding, with Regeneron receiving $326 million to develop a new COVID-19 monoclonal antibody.

White houseDistrict of columbiaUnited statesLeonard schleiferXavier becerraTechnical resources internationalBiomedical advanced researchEmory universityResearch projects agency for healthHuman servicesPublic health solutionsDevelopment authorityDepartment of healthDrug administrationProject nextgenTechnical resources

Regeneron Awarded $326M Government Contract For COVID-19 Antibody Therapy Development - Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) was awarded a government contract valued at up to $326 million on Tuesday.

Leonard schleiferBiomedical advanced researchDevelopment authorityHuman servicesUs department of healthRegeneron pharmaceuticals

Project NextGen to spend $1 4B in search for better COVID drugs, vaccines

BioPharma

Leonard schleiferCenters for diseaseRegeneron pharmaceuticalsHuman servicesGlobal health investmentBiomedical advanced researchDepartment of healthDevelopment authorityPublic health solutionsTechnical resources internationalProject nextgenOperation warp speedDisease controlAssistant secretaryResponse dawno connellRho federal

This biotech name is one of Jim Cramer s favorite stocks and he thinks it can go even higher

“I think it’s going to be worth more,” Jim Cramer said Monday after Regeneron got good news from the FDA on its macular degeneration treatment.

New yorkUnited statesJim cramerLeonard schleiferRegeneron pharmaceuticalsDrug administrationEli lilly

This biotech name is one of Jim Cramer s favorite stocks

"I think it's going to be worth more," Jim Cramer said Monday after Regeneron got good news from the FDA on its macular degeneration treatment.

Jim cramerLeonard schleiferDrug administrationRegeneron pharmaceuticalsEli lillyBiotech and pharmaceuticalsRegeneron pharmaceuticals incStock takesInvestment strategyBreaking news marketsHealth care industryEli lilly and coBusiness news

vimarsana © 2020. All Rights Reserved.